Zemaira NDC 0053-7202

NDC codes

FDA NDC Directory

Product NDC (as listed)0053-7202Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00053-7202Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0053-7202-02	00053720202	1 KIT in 1 CARTON (0053-7202-02) * 76 mL in 1 VIAL, SINGLE-USE (0053-7212-01) * 76 mL in 1 VIAL, SINGLE-USE (0053-7653-80)Marketed from Apr 24, 2019

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Zemaira
Generic name (nonproprietary): .alpha.1-proteinase inhibitor human
Dosage form: Kit
Labeler: CSL Behring LLC
Product type: Plasma derivative
Marketing category: BLA — Biologics License ApplicationApplication BLA 125078
Marketing start: Apr 24, 2019
Listing expires: Dec 31, 2026
Identifiers: Product ID 0053-7202_a60040d6-46ed-4a3b-af7e-528a65b7fca7SPL ID a60040d6-46ed-4a3b-af7e-528a65b7fca7

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N400053720202 followed by a unit qualifier and the quantity

Package 00053-7202-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

Other NDCs under BLA 125078

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under BLA 125078
Product	Strength	Form · route	Labeler	Product NDC
Zemairaalpha-1-proteinase inhibitor human kit	—	KitIntravenous	Fisher Clinical Services Inc.	57516-101
Zemairaalpha-1-proteinase inhibitor human kit	—	KitIntravenous	Fisher Clinical Services Inc.	57516-110
Zemairaalpha-1-proteinase inhibitor human kit	—	KitIntravenous	Fisher Clinical Services Inc.	57516-113
Zemaira.alpha.1-proteinase inhibitor human	—	Kit	CSL Behring LLC	0053-7203
Zemairaalpha-1-proteinase inhibitor human	—	Kit	CSL Behring LLC	0053-7201

Zemaira (.alpha.1-proteinase inhibitor human) NDC 0053-7202